Error! You must javascript enabled to use this form. Please enable Javascript in your browser. A Booming Market Drives the Growth of Cancer Generics Backed by patent expiries of blockbuster drugs and feasible regulatory environment, the cancer generics market is expected to grow at a CAGR of 27% during 2010-2014. View full press release Your Name: Your Email: Subject: Question: We respects your privacy, the information you entered above will not be used to send unsolicited email, and will not be rented or sold to a 3rd party. Your contact information will be shared with the recipient of this message - Privacy Policy Send